Fine N F, Sexton S A, Williams D H
Royal Cornwall Hospital, Truro, Cornwall, UK.
Royal Cornwall Hospital, Truro, Cornwall, UK.
Injury. 2017 Jul;48(7):1575-1578. doi: 10.1016/j.injury.2017.05.030. Epub 2017 May 25.
The Cephalomedullary Nail (CMN) (Zimmer, Warsaw) was introduced in 2010 as part of a multicenter trial to evaluate its performance. At one year the CMN had results in keeping with other intramedullary devices with good union rates and low complication rates. In the second and third years of use an increased rate of implant failure was observed, towards the higher end of the 1-5% nail breakage rate seen in other studies. This study aims to evaluate if there any common features in this cohort of patients.
This is a retrospective cohort study looking at patients who underwent femoral fracture fixation using the cephalomedullary nail between January 2011 and June 2014. The primary outcome measure was implant failure; secondary outcomes were; fracture reduction and bisphosphonate use.
201 patients were included (135 female, 66 male) with an average age of 81 years. Ten (5%) nail breakages occurred in the study period at an average of 39 weeks (24-92); 9 were 125° nails 1 was a 130° nail and all fractured at the lag screw junction.
Implant failure is a recognised complication of intramedullary nailing in cases of non-union. The increased rate of implant failure in our department required a change to a 130° CMN implant and a 3.2mm diameter guide wire for placement of the lag screw. We continue to monitor this difficult group of patients very closely.
2010年引入了髓内钉(CMN)(Zimmer公司,华沙)作为多中心试验的一部分,以评估其性能。在一年时,CMN的结果与其他髓内装置一致,骨愈合率良好且并发症发生率低。在使用的第二和第三年,观察到植入物失败率增加,接近其他研究中1-5%的钉断裂率的较高水平。本研究旨在评估该组患者是否有任何共同特征。
这是一项回顾性队列研究,观察2011年1月至2014年6月间使用髓内钉进行股骨骨折固定的患者。主要结局指标是植入物失败;次要结局指标是骨折复位和双膦酸盐的使用。
纳入201例患者(135例女性,66例男性),平均年龄81岁。在研究期间发生了10例(5%)钉断裂,平均时间为39周(24-92周);9例为125°钉,1例为130°钉,均在拉力螺钉连接处断裂。
植入物失败是髓内钉固定治疗骨不连病例中公认的并发症。我们科室植入物失败率的增加促使我们改用130°的CMN植入物和直径3.2mm的导丝来放置拉力螺钉。我们继续密切监测这一困难的患者群体。